Screening designs for drug development
From MaRDI portal
Publication:5308154
DOI10.1093/biostatistics/kxl031zbMath1121.62099OpenAlexW2142233765WikidataQ33259890 ScholiaQ33259890MaRDI QIDQ5308154
Gary L. Rosner, David Rossell, Peter Mueller
Publication date: 27 September 2007
Published in: Biostatistics (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1093/biostatistics/kxl031
Applications of statistics to biology and medical sciences; meta analysis (62P10) Bayesian problems; characterization of Bayes procedures (62C10) Sequential statistical methods (62L99)
Related Items (4)
Bayesian designs and the control of frequentist characteristics: A practical solution ⋮ A Review of Modern Computational Algorithms for Bayesian Optimal Design ⋮ Bayesian Optimal Design for Phase II Screening Trials ⋮ Decision‐theoretic designs for a series of trials with correlated treatment effects using the Sarmanov multivariate beta‐binomial distribution
Uses Software
This page was built for publication: Screening designs for drug development
